{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:46:23Z","timestamp":1790765183006,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:00:00Z","timestamp":1100044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s00109-004-0600-x","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T11:47:19Z","timestamp":1100000839000},"page":"148-158","source":"Crossref","is-referenced-by-count":104,"title":["Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin"],"prefix":"10.1007","volume":"83","author":[{"given":"Cezary","family":"Watala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Pluta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Golanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Rozalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Czyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zygmunt","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\ufffdzef","family":"Drzewoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,10]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","unstructured":"Colwell JA, the American Diabetes Association (2004) Aspirin therapy in diabetes. Diabetes Care 27 [Suppl 1]:S72?S73","DOI":"10.2337\/diacare.27.2007.S72"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","volume":"88","author":"Gum","year":"2001","unstructured":"Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, Sapp SK, Topol EJ (2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88:230?235","journal-title":"Am J Cardiol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.STR.23.6.851","volume":"23","author":"Sivenius","year":"1992","unstructured":"Sivenius J, Laakso M, Riekkinen P, Smets P, Lowenthal A (1992) European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. Stroke 23:851?854","journal-title":"Stroke"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","volume":"41","author":"Gum","year":"2003","unstructured":"Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ (2003) A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41:961?965","journal-title":"J Am Coll Cardiol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1055\/s-0037-1613290","volume":"88","author":"McKee","year":"2002","unstructured":"McKee SA, Sane DC, Deliargyris EN (2002) Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. Thromb Haemost 88:711?715","journal-title":"Thromb Haemost"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1015324310374","volume":"13","author":"Cambria-Kiely","year":"2002","unstructured":"Cambria-Kiely JA, Gandhi PJ (2002) Possible mechanisms of aspirin resistance. J Thromb Thrombolysis 13:49?56","journal-title":"J Thromb Thrombolysis"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1046\/j.1538-7836.2003.00284.x","volume":"1","author":"Patrono","year":"2003","unstructured":"Patrono C (2003) Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost 1:1710?1713","journal-title":"J Thromb Haemost"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/diab.41.3.261","volume":"41","author":"Mori","year":"1992","unstructured":"Mori TA, Vandongen R, Douglas AJ, McCulloch RK, Burke V (1992) Differential effect of aspirin on platelet aggregation in IDDM. Diabetes 41:261?266","journal-title":"Diabetes"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.2337\/diacare.26.12.3264","volume":"26","author":"Sacco","year":"2003","unstructured":"Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A (2003) Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 26:3264?3272","journal-title":"Diabetes Care"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2003.12.016","volume":"113","author":"Watala","year":"2004","unstructured":"Watala C, Golanski J, Pluta J, Boncler M, Rozalski M, Wieclawska B, Kropiwnicka A, Drzewoski J (2004) Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)?its relation to metabolic control. Thromb Res 113:101?113","journal-title":"Thromb Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2007-1002650","volume":"17","author":"Tschoepe","year":"1991","unstructured":"Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, Gries FA (1991) Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 17:433?438","journal-title":"Semin Thromb Hemost"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-0609.1993.tb00160.x","volume":"50","author":"Pampus","year":"1993","unstructured":"Pampus EC van, Huijgens PC, Zevenbergen A, Twaalfhoven H, van Kamp GJ, Langenhuijsen MM (1993) Influence of aspirin on human megakaryocyte prostaglandin synthesis. Eur J Haematol 50:264?268","journal-title":"Eur J Haematol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/09537109976356","volume":"10","author":"Watala","year":"1999","unstructured":"Watala C, Boncler M, Pietrucha T, Trojanowski Z (1999) Possible mechanisms of the altered platelet volume distribution in type 2 diabetes?may the increased platelet activation contribute to platelet size heterogeneity? Platelets 10:52?60","journal-title":"Platelets"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","volume":"2","author":"Loll","year":"1995","unstructured":"Loll PJ, Picot D, Garavito RM (1995) The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol 2:637?643","journal-title":"Nat Struct Biol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000267336","volume":"25","author":"Cherian","year":"1993","unstructured":"Cherian M, Abraham EC (1993) Glycation of human lens crystallins: effect of age and aspirin treatment. Ophthalmic Res 25:349?354","journal-title":"Ophthalmic Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.20.5.832","volume":"20","author":"Contreras","year":"1997","unstructured":"Contreras I, Reiser KM, Martinez N, Giansante E, Lopez T, Suarez N, Postalian S, Molina M, Gonzalez F, Sanchez MR, Camejo M, Blanco MC (1997) Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM. Diabetes Care 20:832?835","journal-title":"Diabetes Care"},{"key":"CR17","first-page":"313","volume":"36","author":"Hun-Opfer","year":"1986","unstructured":"Hun-Opfer C, Mata-Segreda JF (1986) Non-enzymatic acetylation of proteins by aspirin as protection against the secondary complications of diabetes mellitus. Acta Physiol Pharmacol Latinoam 36:313?316","journal-title":"Acta Physiol Pharmacol Latinoam"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0268-9499(98)80394-9","volume":"12","author":"Jorneskog","year":"1998","unstructured":"Jorneskog G, Fatah K, Blomback M (1998) Fibrin gel structure in diabetic patients before and during treatment with acetylsalicylic acid: a pilot study. Fibrinolysis Proteolysis 12:360?365","journal-title":"Fibrinolysis Proteolysis"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/bbrc.1994.1282","volume":"199","author":"Malik","year":"1994","unstructured":"Malik NS, Meek KM (1994) The inhibition of sugar-induced structural alterations in collagen by aspirin and other compounds. Biochem Biophys Res Commun 199:683?686","journal-title":"Biochem Biophys Res Commun"},{"key":"CR20","first-page":"651","volume":"36","author":"Shastri","year":"1998","unstructured":"Shastri GV, Thomas M, Victoria AJ, Selvakumar R, Kanagasabapathy AS, Thomas K, Lakshmi (1998) Effect of aspirin and sodium salicylate on cataract development in diabetic rats. Indian J Exp Biol 36:651?657","journal-title":"Indian J Exp Biol"},{"key":"CR21","first-page":"1120","volume":"30","author":"Swamy","year":"1989","unstructured":"Swamy MS, Abraham EC (1989) Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo. Invest Ophthalmol Vis Sci 30:1120?1126","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0038-1646320","volume":"68","author":"Winocour","year":"1992","unstructured":"Winocour PD, Watala C, Perry DW, Kinlough-Rathbone RL (1992) Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins. Thromb Haemost 68:577?582","journal-title":"Thromb Haemost"},{"key":"CR23","first-page":"286","volume":"108","author":"Rendell","year":"1986","unstructured":"Rendell M, Nierenberg J, Brannan C, Valentine JL, Stephen PM, Dodds S, Mercer P, Smith PK, Walder J (1986) Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo. J Lab Clin Med 108:286?293","journal-title":"J Lab Clin Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/exer.1999.0680","volume":"69","author":"Swamy-Mruthinti","year":"1999","unstructured":"Swamy-Mruthinti S, Carter AL (1999) Acetyl-L-carnitine decreases glycation of lens proteins: in vitro studies. Exp Eye Res 69:109?115","journal-title":"Exp Eye Res"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/diacare.27.5.1245","volume":"27","author":"Drzewoski","year":"2004","unstructured":"Drzewoski J, Watala C (2004) Is aspirin resistance a real problem in people with type 2 diabetes? Response to Sacco et al. Diabetes Care 27:1245?1246","journal-title":"Diabetes Care"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1081\/JLC-100102372","volume":"23","author":"Hanai","year":"2000","unstructured":"Hanai T, Uchida M, Amao M, Ikeda C, Koizumi K, Kinoshita T (2000) Selective chemiluminescence analysis of amadori form of glycated human serum albumin. J Liq Chrom Rel Technol 23:3119?3131","journal-title":"J Liq Chrom Rel Technol"},{"key":"CR27","unstructured":"Zar J (1999) Biostatistical analysis. Simon & Schuster\/A Viacom, Prentice-Hall"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.2042-7158.1997.tb06794.x","volume":"49","author":"Benedito","year":"1997","unstructured":"Benedito MA (1997) Fluorimetric determination of tissue distribution and differences between the activity of aspirin esterases I and II in mice and rats. J Pharm Pharmacol 49:273?276","journal-title":"J Pharm Pharmacol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0006-2952(01)00777-8","volume":"62","author":"Rozalski","year":"2001","unstructured":"Rozalski M, Boncler M, Golanski J, Watala C (2001) Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation. Biochem Pharmacol 62:1399?1408","journal-title":"Biochem Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-995840","volume":"24","author":"Mammen","year":"1998","unstructured":"Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, Larkin EC, Liles D, Nugent DJ (1998) PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 24:195?202","journal-title":"Semin Thromb Hemost"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/bmj.1.6016.994","volume":"1","author":"Bartlett","year":"1976","unstructured":"Bartlett A, Stableforth P, Voller A (1976) Factor VIII related antigen: measurement by enzyme immunoassay. BMJ 1:994?996","journal-title":"BMJ"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0003-4975(94)90218-6","volume":"57","author":"Ray","year":"1994","unstructured":"Ray MJ, Hawson GA, Just SJ, McLachlan G, O?Brien M (1994) Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 57:981?986","journal-title":"Ann Thorac Surg"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0049-3848(03)00238-X","volume":"109","author":"Watala","year":"2003","unstructured":"Watala C, Golanski J, Rozalski M, Boncler M, Luzak B, Baraniak J, Korczynski D, Drygas W (2003) Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100? Thromb Res 109:299?306","journal-title":"Thromb Res"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00109-002-0386-7","volume":"80","author":"Boncler","year":"2002","unstructured":"Boncler MA, Golanski J, Paczuski R, Watala C (2002) Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation. J Mol Med 80:796?801","journal-title":"J Mol Med"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0049-3848(89)90294-6","volume":"56","author":"Walkowiak","year":"1989","unstructured":"Walkowiak B, Michalak E, Koziolkiewicz W, Cierniewski CS (1989) Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Thromb Res 56:763?766","journal-title":"Thromb Res"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76?85","journal-title":"Anal Biochem"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj2030313","volume":"203","author":"Johnson","year":"1982","unstructured":"Johnson P, Garland PB (1982) Fluorescent triplet probes for measuring the rotational diffusion of membrane proteins. Biochem J 203:313?321","journal-title":"Biochem J"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(94)90081-7","volume":"167","author":"Sashidhar","year":"1994","unstructured":"Sashidhar RB, Capoor AK, Ramana D (1994) Quantitation of epsilon-amino group using amino acids as reference standards by trinitrobenzene sulfonic acid. A simple spectrophotometric method for the estimation of hapten to carrier protein ratio. J Immunol Methods 167:121?127","journal-title":"J Immunol Methods"},{"key":"CR39","doi-asserted-by":"crossref","unstructured":"Armitage P, Berry G, Matthews JNS (2002) Statistical methods in medical research. Blackwell, Oxford","DOI":"10.1002\/9780470773666"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0049-3848(02)00348-1","volume":"107","author":"Hasegawa","year":"2002","unstructured":"Hasegawa Y, Suehiro A, Higasa S, Namba M, Kakishita E (2002) Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus. Thromb Res 107:319?323","journal-title":"Thromb Res"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"H1480","DOI":"10.1152\/ajpheart.2001.280.4.H1480","volume":"280","author":"Li","year":"2001","unstructured":"Li Y, Woo V, Bose R (2001) Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus. Am J Physiol Heart Circ Physiol 280:H1480?H1489","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","volume":"99","author":"Davi","year":"1999","unstructured":"Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C (1999) In vivo formation of 8-iso-prostaglandin F2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99:224?229","journal-title":"Circulation"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/diacare.26.7.2181","volume":"26","author":"Colwell","year":"2003","unstructured":"Colwell JA, Nesto RW (2003) The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care 26:2181?2188","journal-title":"Diabetes Care"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.326.7380.82","volume":"326","author":"Friend","year":"2003","unstructured":"Friend M, Vucenik I, Miller M (2003) Research pointers: platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ 326:82?83","journal-title":"BMJ"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood.V68.4.886.886","volume":"68","author":"DiMinno","year":"1986","unstructured":"DiMinno G, Silver MJ, Cerbone AM, Murphy S (1986) Trial of repeated low-dose aspirin in diabetic angiopathy. Blood 68:886?891","journal-title":"Blood"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1139\/y94-045","volume":"72","author":"Winocour","year":"1994","unstructured":"Winocour PD (1994) Platelets, vascular disease, and diabetes mellitus. Can J Physiol Pharmacol 72:295?303","journal-title":"Can J Physiol Pharmacol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0006-2952(93)90288-8","volume":"45","author":"Watala","year":"1993","unstructured":"Watala C, Gwozdzinski K (1993) Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes. Biochem Pharmacol 45:1343?1349","journal-title":"Biochem Pharmacol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-004-0600-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-004-0600-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-004-0600-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T23:06:30Z","timestamp":1585955190000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-004-0600-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,10]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1007\/s00109-004-0600-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,10]]}}}